Impactos da nanotecnologia na saúde : produção de medicamentos

• Autor(a) principal: Dimer, Frantiescoli Anversa
• Data de Publicação: 2013
• Outros Autores: Friedrich, Rossana Barcellos, Beck, Ruy Carlos Ruver, Guterres, Silvia Stanisçuaski, Pohlmann, Adriana Raffin
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Repositório Institucional da UFRGS
• Texto Completo: http://hdl.handle.net/10183/97163
• topic: Nanotecnologia; Producao de medicamentos; Pharmaceutical nanotechnology; Nanomedicine; Drug

Several studies have described the benefits of nanoscience and nanotechnology (N&N) in different sectors such as agriculture, energy, environmental preservation, and public health. The rapid evolution of N&N can be shown through a panoramic analysis of scientific papers and patents. In the area of public health, it is estimated that the global market for nanotechnology products will expand to 160 billion U.S. dollars in 2015. The Brazilian government has also strengthened its innovative potential in N&N through economic subsidies, as observed for other countries. This review is focused on the current landscape of N&N in a therapeutic context, highlighting the development of nanotech-products produced with biocompatible and biodegradable materials that are already commercially available or under investigation. Most studies under investigation are focused on the development of nanotechnology-based formulations intended for treatment of cancer, inflammatory, cardiovascular, and neurological diseases. Although there are several advantages of N&N in healthcare, many challenges have to be conquered to increase the availability of nanotechnology products in toxicological, preclinical and clinical studies, scale-up, regulatory, and private investments.